Equine S100-A8 antibody and antigen (recombinant protein)

Diagnostic anti-Equine S100-A8 antibodies pairs and antigen for animal health (animal Equine/Horse intestinal inflammation) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-S100-A8-Ag01Equine S100-A8$3090.00
GMP-EQU-S100-A8-Ab01Anti-Equine S100-A8 mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-S100-A8-Ab02Anti-Equine S100-A8 mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-S100-A8-Ab03Anti-Equine S100-A8 human monoclonal antibody (mAb)$3090.00
GMP-EQU-S100-A8-Ab04Anti-Equine S100-A8 human monoclonal antibody (mAb)$3090.00

Size： 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-S100-A8-Ag01
Product NameEquine S100-A8
Target/BiomarkerEquine S100-A8
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine S100-A8 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in S100-A8 level test of animal Equine/Horse with intestinal inflammation.
TagHis
Reconized/Reactive SpecicsEquine S100-A8
Product descriptionRecombinant Equine S100-A8 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-S100-A8-Ab01,GMP-EQU-S100-A8-Ab02
Target/BiomarkerEquine S100-A8
Product NameAnti-Equine S100-A8 mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine S100-A8 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine S100-A8 antibodies in Equine S100-A8 level test of animal Equine/Horse with intestinal inflammation.
Product descriptionAnti-Equine S100-A8 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine S100-A8 antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-S100-A8-Ab03,GMP-EQU-S100-A8-Ab04
Target/BiomarkerEquine S100-A8
Product NameAnti-Equine S100-A8 human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine S100-A8 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine S100-A8 antibodies in Equine S100-A8 level test of animal Equine/Horse with intestinal inflammation.
Product descriptionAnti-Equine S100-A8 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Equine S100-A8, a multifaceted calcium-binding protein, takes center stage in the intricate world of equine biology. Structurally, it forms a heterodimer with its counterpart, S100-A9, to create the calprotectin complex. In horses, this dynamic duo operates primarily within the confines of immune cells, particularly neutrophils and monocytes, where it plays a pivotal role in orchestrating the immune response.

    The hallmark of Equine S100-A8 is its rapid response to inflammatory cues. When the equine body detects a threat, whether it be a bacterial invader or tissue damage, immune cells spring into action. Equine S100-A8 is released from these activated cells into the bloodstream, where it embarks on its mission as a sentinel of inflammation. It serves as a signaling molecule, communicating with specific receptors like Toll-like receptor 4 (TLR4). This interaction triggers a cascade of events, leading to the recruitment of more immune cells to the site of injury or infection.

    Beyond its role in inflammation, Equine S100-A8 has a hand in tissue repair. It influences the migration and adhesion of neutrophils, helping to resolve inflammation and promote the healing of injured tissues. This dual nature of Equine S100-A8, as both a herald of inflammation and a facilitator of tissue recovery, underscores its significance in equine health.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.